Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9837159 | 0.91 | ALDH1A1 (0.46) | ALDH1A1CYP3A4ALOX15TDP1GAA | |
| SCHEMBL17129799 | 0.87 | ALDH1A1 (0.54) | ALDH1A1CYP3A4ALOX15TDP1GAA | |
| SCHEMBL11230598 | 0.84 | ALDH1A1 (0.46) | ALDH1A1CYP3A4ALOX15TDP1GAA | |
| SCHEMBL7700786 | 0.80 | TSHR (0.41) | ALDH1A1CYP3A4ALOX15TDP1HSD17B10 | |
| SCHEMBL18308881 | 0.79 | ALDH1A1 (0.43) | ALDH1A1CYP3A4ALOX15TDP1GAA | |
| SCHEMBL11451383 | 0.78 | ALDH1A1 (0.43) | ALDH1A1CYP3A4ALOX15TDP1GAA | |
| SCHEMBL9837141 | 0.78 | ALDH1A1 (0.46) | ALDH1A1CYP3A4ALOX15TDP1GAA | |
| SCHEMBL1891917 | 0.78 | ALDH1A1 (0.43) | ALDH1A1CYP3A4ALOX15TDP1GAA | |
| SCHEMBL4593867 | 0.78 | ALOX15 (0.46) | ALDH1A1CYP3A4ALOX15TDP1GAA | |
| SCHEMBL1784164 | 0.78 | ALDH1A1 (0.46) | ALDH1A1CYP3A4ALOX15TDP1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7935669-B2 | Compounds for a controlled release of active molecules | FIRMENICH SA (CH) | 2011-05-03 | — | — | US | disclosed |
| US-7723286-B2 | Compounds for a controlled release of active molecules | FIRMENICH SA (CH) | 2010-05-25 | — | — | US | disclosed |
| US-20090181878-A1 | COMPOUNDS FOR A CONTROLLED RELEASE OF ACTIVE MOLECULES | FIRMENICH SA | 2009-07-16 | — | — | US | disclosed |
| EP-1460994-B1 | COMPOUNDS FOR A CONTROLLED RELEASE OF ACTIVE MOLECULES | FIRMENICH & CIE (CH) | 2008-10-01 | — | — | EP | disclosed |
| US-20040220074-A1 | Compounds for a controlled release of active molecules | FIRMENICH SA (CH) | 2004-11-04 | — | — | US | disclosed |
| EP-0012436-B1 | PROCESS FOR HYDROGENATION OF 2,6,6-TRIMETHYL CYCLOHEXENE DERIVATIVES, PRODUCTS PRODUCED THEREBY AND ORGANOLEPTIC USES OF SAID PRODUCTS | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1982-11-24 | — | — | EP | disclosed |
| US-4360032-A | Use of hydrogenated derivatives of 2,6,6-trimethyl-cyclohexene derivatives in augmenting or enhancing the aroma or taste of smoking tobacco and smoking tobacco articles | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1982-11-23 | — | — | US | disclosed |
| US-4324704-A | PERFUMES CONTAINING HYDROGENATION PRODUCTS OF DAMASCENONE | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1982-04-13 | — | — | US | disclosed |
| US-4315953-A | Process for augmenting or enhancing the aroma or taste of raspberry flavored foodstuffs using 2,6,6-trimethylcyclohexene derivatives | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1982-02-16 | — | — | US | disclosed |
| US-4313842-A | FOR DETERGENTS | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1982-02-02 | — | — | US | disclosed |
| US-4311754-A | FOR FABRIC SOFTENERS | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1982-01-19 | — | — | US | disclosed |
| US-4292447-A | Process for hydrogenation of 2,6,6-trimethyl cyclohexene derivatives, products produced thereby and organoleptic uses of said products | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1981-09-29 | — | — | US | disclosed |
| EP-0012436-A1 | Process for hydrogenation of 2,6,6-trimethyl cyclohexene derivatives, products produced thereby and organoleptic uses of said products | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1980-06-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040220074-A1 | Compounds for a controlled release of active molecules | ACLY, PTGES, NOTUM | ALDH1A1 355/4885CYP3A4 199/4885ALOX15 58/4885 |
| US-20090181878-A1 | COMPOUNDS FOR A CONTROLLED RELEASE OF ACTIVE MOLECULES | ACLY, PTGES, PPOX | ALDH1A1 315/4885CYP3A4 208/4885ALOX15 103/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.